Your search matched 49 results
Impacts of Telemedicine on Patient Engagement During COVID-19 | Blog
Understanding the impact that telemedicine has had on HCP behaviors including prescribing in the changing COVID-19 landscape.
How Health Tech is Helping Countries Around the World Tackle Coronavirus | Blog
With an increasing number of coronavirus cases popping up around the world, countries are taking action by leveraging innovative health tech to protect the safety of the public without compromising the care they need.
Adapt, Don’t Cancel: How to Go Virtual When Attendees Can’t Travel | Perspectives
Virtual delivery requires you to rethink your content and approaches.
Leading Through Uncertainty Amidst the Global Pandemic | Perspectives
Communities across the world are facing unprecedented times with a global pandemic affecting over 100+ countries.
The Syneos Health Podcast, Coronavirus Special Edition: The Personal Experience | Perspectives
The COVID-19 (coronavirus) outbreak continues to grow worldwide – recently declared by the World Health Organization as a global pandemic – with widespread personal, medical, and business implications.
Pivot Past the Pandemic | Perspectives
Life sciences commercialization in the COVID-19 era and beyond
Best Practices: Social Media Content and Activity During COVID-19 | Perspectives
In this PM360 article, Steve Marino, Managing Director of Digital & Social Strategy at Syneos Health Communications, shares "guidance (that) can help marketers navigate their way as they make decisions about what types of content to post, and what not to post."
COVID-19: Optimizing Promotions with HCP Preferences | Perspectives
Understanding HCP concerns and preferences for personal promotions in the time of COVID-19.
It's Time for a Digital Reset | Perspectives
What should the evolution of your digital strategy look like through COVID-19 and beyond?
Engaging Media During Unprecedented Times: Insights for Your Business From a National Press Survey | Perspectives
To help Syneos Health public relations agencies and clients navigate the media relations landscape during the pandemic, we conducted a survey in which we asked journalists to share insights on their coverage of health, medical and pharma/biotech industry topics.
2020 Employee Communications and Behavioral Science Contingency | Perspectives
Recommendations for activities to inform and engage
Our Virtual Reality | Perspectives
Virtual collaboration isn’t the future of work – it's the wave of the present
COVID-19: How are Payers Managing These Days? | Perspectives
How are payers responding to COVID-19?
MM&M eBook: Marketing in a Crisis | In The Media
In the "Marketing in a Crisis" eBook by MM&M, Scott Page of GSW, a Syneos Health company, says: “We are in this business of healthcare because it is a higher calling."
The Syneos Health Podcast, Coronavirus Special Edition: Telemedicine in the Age of COVID-19 | Perspectives
In this episode in our Coronavirus Special Edition Series, Jodi Scarbrough, Director of Custom Research at Syneos Health, discusses the impact of the COVID-19 on the adoption of telemedicine and teledetailing, and how these platforms might play out post-pandemic.
Four Critical Dynamics for Virtual Collaboration | Blog
Achieving success in the current global context now hinges on “the virtual meeting” – the most important method for teams to stay connected, troubleshoot, and drive results.
Payer Priorities in a Pandemic | In The Media
What are payers focused on during the COVID-19 pandemic?
There’s a Looming Mental Health Crisis but Tech is Here to Help | Blog
The COVID-19 pandemic is steadily increasing our risk for a mental health crisis around the world.
COVID vaccine deemed essential to re-opening activities—But, no-thanks, it’s not for me! | Blog
With the dramatic impact that COVID 19 has had on work, school, social engagements, and overall life as we know it, one would think that people would be anxious to be vaccinated.
Here are a Few Changes We Can Expect to See in Our World After COVID | Blog
COVID-19 has accelerated the rate at which we’re seeing change happening around us.
As Moods Shift Around COVID, Pharma Makes New Social Plans | Blog
As some people near the end of their third month of lockdown, many COVID-19-related trends are starting to look quite different than they did toward the beginning of the pandemic.
Clear, Consistent Healthcare Communication: Lessons from COVID-19 | Blog
Patients are often at risk when presented with mixed messages.
Big Pharma Fund Fights Menacing Superbugs | Blog
COVID-19 treatment regimens are underscoring the threat of antimicrobial resistance, which threatens to kill as many as 20 million people per year by 2050.
Novo Nordisk Tailors Launch for COVID-era Customers | Blog
Novo Nordisk’s new diabetes drug seemed all set for launch in early 2020, a time nobody could plan for.
COVID’s Consequences Clearer as Cancer Cases Climb | Blog
At a virtual conference hosted last month by the Milken Institute, which aims to create economic solutions to contemporary healthcare challenges, experts explored some post-COVID realities starting to materialize.
Fors Marsh Group Selected by HHS to Build $250 Million Public Coronavirus Campaign | Blog
The Department of Health and Human Services (HHS) has selected the Fors Marsh Group to handle the new $250 million coronavirus campaign.
Looking Beyond COVID-19, Walgreens to Open Clinics in Underserved Communities | Blog
Ten years after acquiring its competitor Duane Reade, Walgreens has set its sights on a whole different type of growth, announcing its plan to establish doctor’s offices in hundreds of its familiar brick-and-mortar stores.
Why Hospitals Really Like the Changes They Made for COVID-19 | Blog
As the pandemic surged, New York City’s Mt.
Healthcare More Streamlined, Consumerized Post COVID-19 | Blog
Though once overwhelmed by the pandemic, many healthcare systems have already restructured themselves after learning critical lessons from COVID-19.
First COVID-19 Treatment Approved by FDA | Blog
The Food and Drug Administration (FDA) has approved the use of Veklury (remdesivir) for use in adult and adolescent patients 12 years of age and older for the treatment of COVID-19 in instances that require hospitalization.
Already have a RSS feed reader?
